Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 4546 AL 4560

[Progress of dementia medicine: Special reference to Alzheimer's disease]

Utsumi K.

Hokkaido Igaku Zasshi. 2014 May;89(1):21-3.

Matrix metalloproteinases and their multiple roles in Alzheimer's disease

Wang XX, Tan MS, Yu JT, Tan L.

Biomed Res Int. 2014;2014:908636. doi: 10.1155/2014/908636. Epub 2014 Jun 24.

The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

Molinuevo JL, Blennow K, Dubois B, Engelborghs S, Lewczuk P, Perret-Liaudet A, Teunissen CE, Parnetti L.

Alzheimers Dement. 2014 Nov;10(6):808-17. doi: 10.1016/j.jalz.2014.03.003. Epub 2014 Aug 20.

Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease

Babić M, Svob Štrac D, Mück-Šeler D, Pivac N, Stanić G, Hof PR, Simić G.

Croat Med J. 2014 Aug 28;55(4):347-65. doi: 10.3325/cmj.2014.55.347.

Early neuropsychological detection of Alzheimer's disease

Bastin C, Salmon E.

Eur J Clin Nutr. 2014 Nov;68(11):1192-9. doi: 10.1038/ejcn.2014.176. Epub 2014 Sep 3.

Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study

Chouraki V, Beiser A, Younkin L, Preis SR, Weinstein G, Hansson O, Skoog I, Lambert JC, Au R, Launer L, Wolf PA, Younkin S, Seshadri S.

Alzheimers Dement. 2015 Mar;11(3):249-57.e1. doi: 10.1016/j.jalz.2014.07.001. Epub 2014 Sep 10.

3.0 T MRI arterial spin labeling and magnetic resonance spectroscopy technology in the application of Alzheimer's disease

Zou JX, Wang MJ, Lei XJ, Chen XG.

Exp Gerontol. 2014 Dec;60:31-6. doi: 10.1016/j.exger.2014.09.009. Epub 2014 Sep 16.

Volatile organic compounds (VOCs) fingerprint of Alzheimer's disease

Mazzatenta A, Pokorski M, Sartucci F, Domenici L, Di Giulio C.

Respir Physiol Neurobiol. 2015 Apr;209:81-4. doi: 10.1016/j.resp.2014.10.001. Epub 2014 Oct 13.

Increased CSF APPs-α levels in patients with Alzheimer disease treated with acitretin

Endres K, Fahrenholz F, Lotz J, Hiemke C, Teipel S, Lieb K, Tüscher O, Fellgiebel A.

Neurology. 2014 Nov 18;83(21):1930-5. doi: 10.1212/WNL.0000000000001017. Epub 2014 Oct 24.

DTI-MRI biomarkers in the search for normal pressure hydrocephalus aetiology: a review

Hoza D, Vlasák A, Hořínek D, Sameš M, Alfieri A.

Neurosurg Rev. 2015 Apr;38(2):239-44; discussion 244. doi: 10.1007/s10143-014-0584-0. Epub 2014 Oct 28.

A single-dose pilot trial of intranasal rapid-acting insulin in apolipoprotein E4 carriers with mild-moderate Alzheimer's disease

Rosenbloom MH, Barclay TR, Pyle M, Owens BL, Cagan AB, Anderson CP, Frey WH 2nd, Hanson LR.

CNS Drugs. 2014 Dec;28(12):1185-9. doi: 10.1007/s40263-014-0214-y.

Emerging concepts in Alzheimer's disease

Vinters HV.

Annu Rev Pathol. 2015;10:291-319. doi: 10.1146/annurev-pathol-020712-163927. Epub 2014 Oct 29.

Advances in MRI biomarkers for the diagnosis of Alzheimer's disease

Kehoe EG, McNulty JP, Mullins PG, Bokde AL.

Biomark Med. 2014;8(9):1151-69. doi: 10.2217/bmm.14.42.

Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians

Asih PR, Chatterjee P, Verdile G, Gupta VB, Trengove RD, Martins RN.

Neurodegener Dis Manag. 2014;4(5):363-78. doi: 10.2217/nmt.14.29.

Amyloid-beta and depression in healthy older adults: a systematic review

Harrington KD, Lim YY, Gould E, Maruff P.

Aust N Z J Psychiatry. 2015 Jan;49(1):36-46. doi: 10.1177/0004867414557161. Epub 2014 Nov 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias